Ultraplex 150 mg

Ultraplex 150 mg contains a blend of drostanolone propionate, testosterone propionate, and trenbolone acetate. It is not approved for human use as a combination product, and trenbolone is not approved for human use at all. In non-medical bodybuilding contexts, it is commonly referenced during cutting phases for muscle hardening, vascularity, and fat loss, though such use falls outside approved indications.

Due to the short-acting esters in the blend (propionate and acetate), Ultraplex 150 mg is typically referenced as being administered every other day or daily to maintain stable blood levels. This is distinct from longer-acting preparations, which can be administered less frequently.

Yes. This blend is profoundly suppressive to the hypothalamic-pituitary-gonadal axis, and post-cycle therapy is commonly recommended after a cycle. Agents such as Clomiplex or Tamoxiplex are commonly referenced for this purpose. Due to the short-acting esters, PCT can typically begin sooner after the final injection.

Drostanolone propionate provides muscle hardening and anti-estrogenic effects. Testosterone propionate serves as a base compound to support anabolic activity and mitigate libido-related side effects. Trenbolone acetate contributes potent anabolic activity and fat loss effects. Together, these compounds are referenced for producing a hard, dry, vascular physique.

Due to the short-acting esters, effects are sometimes reported within the first week of use in bodybuilding discussions. Individual response varies considerably, and these timelines are based on non-medical user reports rather than controlled clinical data.

There is no universally "best" cut mix. Ultraplex 150 mg combines drostanolone, testosterone, and trenbolone, while other preparations may combine different compounds. The appropriate choice depends on individual goals, experience level, and tolerance for side effects.

Ultraplex 150 mg is a cut mix blend containing drostanolone propionate, testosterone propionate, and trenbolone acetate. Trinaplex 150 is a tri-trenbolone blend containing three trenbolone esters (acetate, enanthate, and hexahydrobenzylcarbonate). The two products have different compound compositions and intended applications.

Ultraplex 150 mg is a multi-compound blend containing drostanolone, testosterone, and trenbolone. Mastaplex 100 is a single-compound product containing only drostanolone propionate. The blend provides additional anabolic and fat-loss effects from testosterone and trenbolone, while the single-compound product allows for independent dose adjustment.

In non-medical bodybuilding contexts, 450 mg per week is within the commonly referenced range of 150–450 mg per week for men. Ultraplex 150 mg contains 150 mg/mL, so 450 mg would equal 3 mL per week. Due to the severity of side effects, this blend is generally considered an advanced compound.

Ultraplex 150 mg is a 3-compound cut mix at 150 mg/mL (50 mg drostanolone propionate, 50 mg testosterone propionate, and 50 mg trenbolone acetate). It is supplied in a 10 mL vial, giving 1,500 mg of total labeled compound content per vial.

Lab testing information for Ultraplex 150 mg is not available on this page. For product-specific testing inquiries, please contact customer support.

Ultraplex 150 mg is generally not recommended for women due to the high virilization risk from trenbolone and drostanolone. Androgenic effects including voice deepening and clitoral enlargement are possible and may be irreversible. Women considering any anabolic steroid use should be aware of these risks.